期刊文献+

超重或肥胖与不同肝功能指标间的关系研究 被引量:5

Association between Overweight or Obesity and Different Indices of Liver Function
下载PDF
导出
摘要 目的:研究超重或肥胖与不同肝功能指标间的关系。方法:在体检人群中选择192例受检者,分别测量身高、体重、血压,检测血脂、血糖、肝功能相关多项指标。结果:超重或肥胖者表现出多项代谢异常,包括:血压升高、血糖升高、血脂紊乱。与正常体重组比较,超重或肥胖组的肝功能相关血清酶水平均出现显著的升高(P〈0.05)。调整年龄和性别变量后的多因素回归分析提示,超重或肥胖组谷丙转氨酶异常发生的危险性是正常体重组的2.405倍,95% CI (清除率)为1.121~5.157。结论:超重或肥胖与肝功能相关血清酶水平升高相关。 To study the association between overweight or obesity and different indices of liver function. Methods: A total of 192 subjects were selected and their body weight, height, blood pressure and biochemistry items including fasting blood glucose, lipid levels and indices of liver function were detected. Results: The overweight or obese subjects exhibited metabolic abnormalities, including high blood pressure, hyperglycemia and hyperlipemia. Compared with normal weight group, the liver function related serum enzyme levels of overweight or obese group were significantly increased (P〈0.05). The results of multivariate logistic regression analysis after adjusted by age and gender showed that the OR value for alanine aminotransferase abnormalities in subjects with overweight or obesity was 2.405 times over normal weight subjects (95% CI: 1.121-5.157). Conclusion: Overweight or obesity is associated with elevated liver function related serum enzyme levels.
出处 《药学与临床研究》 2014年第4期356-358,共3页 Pharmaceutical and Clinical Research
基金 国家自然科学基金项目(81302817) 江苏省六大人才高峰计划项目(WSN-027) 南京药学会常州四药科研项目(2013YX006)
关键词 超重 肥胖 肝功能指标 Overweight Obesity indices of liver function
  • 相关文献

参考文献12

  • 1Stefan N, Haring HU, Hu FB, et al. Metaboli.ally healthy obesity: elfidemiology, mechanisms, and 'linical impli'ations [J]. Lancet Diabetes Endocrinol, 2013, 1(2): 152-62.
  • 2Wang H, Wang J, l,iu MM, et al. Epidemiology of general obesity, abdominal obesity and related risk fac- tors in urban aduhs from 33 communities of Northeast China: the CHPSNE study [J]. BMC Public Health, 2012, 12: 967.
  • 3Niu J, Seo I)C. Central obesity and hypertension in Chinese adults: A 12-year longitudinal examinatiun[J]. Prey Med. 2014, 62C: 113-8.
  • 4Klnp B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets [J]. Nutrients, 2013, 5 (4): 1218-40.
  • 5Pagadala MR, McCullough AJ. Non-alcoholic fatty liwr disease and obesity: no! all about body mass index[J]. Am J Gttroenterol, 2012, (12): 1859-61.
  • 6中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3062
  • 7Tchernof A, Despr6s JP. PathophysMogy of human vis- ceral obesity: an update [J]. Physiol Rev, 2013, 93(1): 359-404.
  • 8Lear SA, Lesser IA. A review of obesity and body fat distribution and its rt.lationship to cardio-metabolic risk in men and women of Chinese origin [J].Hematol Discord Drug Ttlrgets, 2012, 12(2): 113-8.
  • 9Smith AG, Singleton JR. Obesity and hyperlipid'nlia are risk fa<'tors fir early diabeti{' neuropathy[J]. J Dia- betes Complictaions, 2013, 27(5): 436-42.
  • 10Fock KM, Khoo J. Diet and exercise in management of obesity and overweight [J]. J GtLtroenterol Hepatol, 2013, 28 Suppl 4: 59-63.

二级参考文献3

共引文献3061

同被引文献46

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部